Literature DB >> 4087699

Effect of inorganic phosphate on serum ionized calcium concentration in vitro: a reassessment of the "trade-off hypothesis".

A J Adler, N Ferran, G M Berlyne.   

Abstract

The development of secondary hyperparathyroidism in uremia is thought to be due, in part, to the retention of inorganic phosphate which, as proposed by the "trade-off hypothesis", lowers serum ionized calcium by means of CaHPO4 complex formation. To study this hypothesis, free from hormonal or physiological influence, the effect of changes in inorganic phosphate concentration on calcium ion concentration was examined in vitro in serum and protein-free aqueous solutions. The findings of this study demonstrate that the mean change in ionized calcium in aqueous solution is -0.019 +/- 0.001 mM per 1 mM change in inorganic phosphate, and is not significantly different in serum where the mean change in ionized calcium is -0.018 +/- 0.003 mM per 1 mM change in inorganic phosphate. The results in both aqueous solutions and sera agree closely with values predicted from the K'CaHPO4. Based on these results, the serum inorganic phosphate would have to increase by 1.2 mM (3.7 mg%) before the serum ionized calcium would fall sufficiently (0.025 mM) to stimulate the parathyroid glands. These results indicate that an increase in serum inorganic phosphate to as great as 1 mM/liter does not produce a fall in serum ionized calcium by means of direct physicochemical CaHPO4 complex formation great enough to account for the development of secondary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4087699     DOI: 10.1038/ki.1985.220

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Phosphate and Endothelial Function: How Sensing of Elevated Inorganic Phosphate Concentration Generates Signals in Endothelial Cells.

Authors:  Nima Abbasian; Alan Bevington; Dylan Burger
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  The enigma of hyperparathyroidism in hypophosphatemic rickets.

Authors:  Claus Peter Schmitt; Otto Mehls
Journal:  Pediatr Nephrol       Date:  2004-03-11       Impact factor: 3.714

3.  Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.

Authors:  N A Hamdy; J A Kanis; M N Beneton; C B Brown; J R Juttmann; J G Jordans; S Josse; A Meyrier; R L Lins; I T Fairey
Journal:  BMJ       Date:  1995-02-11

4.  Influence of proton pump inhibitors and histamine H2 receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review.

Authors:  Masaomi Tatsuzawa; Ryuichi Ogawa; Atsushi Ohkubo; Kazuyo Shimojima; Kunimi Maeda; Hirotoshi Echizen; Akihisa Miyazaki
Journal:  J Pharm Health Care Sci       Date:  2016-11-22

5.  Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.

Authors:  Kenneth R Phelps
Journal:  Nutrients       Date:  2017-04-26       Impact factor: 5.717

Review 6.  Current Understanding of Mineral and Bone Disorders of Chronic Kidney Disease and the Scientific Grounds on the Use of Exogenous Parathyroid Hormone in Its Management.

Authors:  Michael Pazianas; Paul Dennis Miller
Journal:  J Bone Metab       Date:  2020-02-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.